Dynamics of Plasmodium species and genotype diversity in adults with asymptomatic infection in Gabon
With 249 million estimated cases and 608,000 deaths worldwide in 2022 [1], malaria remains a public health concern. In endemic areas, individuals can be infected by different Plasmodium species and distinct genotypes of the same species. In serially collected samples, alleles disappearance and reappearance over time was described in asymptomatic infections, raising the question of whether a single blood sample is sufficient to characterize parasite diversity within-host [2]. (Source: International Journal of Infectious Diseases)
Source: International Journal of Infectious Diseases - March 16, 2024 Category: Infectious Diseases Authors: Juliana Inoue, Annika Galys, Miriam Rodi, Dorothea Ekoka Mbassi, Ghyslain Mombo-Ngoma, Ay ôla A. Adegnika, Michael Ramharter, Rella Zoleko-Manego, Peter G. Kremsner, Benjamin Mordmüller, Jana Held Source Type: research

Next-Generation Vaccines for Tropical Infectious Diseases
Tropical infectious diseases impact on the quality of life across a large proportion of the global population. To meet the objectives of the World Health Organisation (WHO) Neglected Tropical Diseases and Malaria 2021-2030 roadmaps [1], the building of widespread capacity for the successful control and elimination of tropical infectious diseases over the next decade remains crucial. Ongoing advancements in the development of novel, effective and targeted vaccines play an integral role in the success of infectious diseases management worldwide [1]. (Source: International Journal of Infectious Diseases)
Source: International Journal of Infectious Diseases - March 16, 2024 Category: Infectious Diseases Authors: Tammy Allen, Maria Eugenia Castellanos, Paul Giacomin, Nadira D Karunaweera, Andreas Kupz, Juan Carlos LoL, Dileep Sharma, Suchandan Sikder, Bemnet Tedla, Liza van Eijk, Danica Vojisavljevic, Guangzu Zhao, Saparna Pai Source Type: research

Dynamics of asymptomatic Plasmodium falciparum and Plasmodium vivax infections and their infectiousness to mosquitoes in a low transmission setting of Ethiopia: a longitudinal observational study
Recent progress in malaria control has stalled in many endemic settings and gains are threatened by emerging biological, social and economic challenges [1]. Despite challenges, malaria control in Ethiopia remained on track with an aspirational target for elimination in selected low transmission settings by 2030 [2]. There is increased awareness of the widespread presence of Plasmodium infections that neither elicit acute symptoms nor treatment seeking behavior in low transmission settings [3 –5]. (Source: International Journal of Infectious Diseases)
Source: International Journal of Infectious Diseases - March 13, 2024 Category: Infectious Diseases Authors: Elifaged Hailemeskel, Surafel K. Tebeje, Jordache Ramjith, Temesgen Ashine, Kjerstin Lanke, Sinknesh W. Behaksra, Tadele Emiru, Tizita Tsegaye, Abrham Gashaw, Soria Kedir, Wakweya Chali, Endashaw Esayas, Temesgen Tafesse, Haile Abera, Mikiyas Gebremichael Source Type: research

Transformative potential of Artificial Intelligence on healthcare and research in Africa
The rise of Artificial Intelligence (AI) stands out as a revolutionary technological force, surpassing the transformative impact observed during the transition to web and mobile technologies.[1,2] Advances in technology present opportunities for enhancing scientific discovery, accelerating human progress, and improving quality of life. AI, a broad term covering machine and deep learning algorithms emulating human intelligence, has led to the development of various algorithms aiding tasks in public health, from workflow optimization to diagnostics and forecasting. (Source: International Journal of Infectious Diseases)
Source: International Journal of Infectious Diseases - March 13, 2024 Category: Infectious Diseases Authors: Moses J Bockarie, Rashid Ansumana, Shingai Grace Machingaidze, Dziedzom K. de Souza, Patrick Fatoma, Alimuddin Zumla, Shui-Shan Lee Tags: Editorial Source Type: research

Editorial Board
(Source: International Journal of Infectious Diseases)
Source: International Journal of Infectious Diseases - March 12, 2024 Category: Infectious Diseases Source Type: research

Publisher's Note
(Source: International Journal of Infectious Diseases)
Source: International Journal of Infectious Diseases - March 12, 2024 Category: Infectious Diseases Source Type: research

Prevalence and risk factors of post-coronavirus disease 2019 condition among children and adolescents in Japan: A matched case-control study in the general population
Coronavirus disease 2019 (COVID-19), with over 769 million confirmed cases worldwide as of July 2023, 1is increasingly prevalent among children and adolescents. Children and adolescents are more likely to experience asymptomatic or milder forms of acute severe acute respiratory syndrome coronavirus 2 (SARS ‑CoV‑2) infection than adults. 2 The increasing number of infected children and adolescents raises concerns about the long-term impact of SARS-CoV-2 infection, known as post-COVID-19 condition (PPC). (Source: International Journal of Infectious Diseases)
Source: International Journal of Infectious Diseases - March 12, 2024 Category: Infectious Diseases Authors: Mariko Hosozawa, Miyuki Hori, Mina Hayama-Terada, Iba Arisa, Yoko Mutou MPH, Akihiko Kitamura, Yoshihiro Takayama, Hiroyasu Iso Source Type: research

Screening for Latent Tuberculosis in Migrants – Status Quo and Future Challenges
It has been previously estimated that the global prevalence of latent TB infection (LTBI) is 24% of the world's population [1;2]. The World Health Organization (WHO) estimated in 2023 that 1.8 billion people are infected with Mycobacterium tuberculosis, but without clinical symptoms of active tuberculosis, which is the definition of latent TB infection [3;4]. This represents a 4.5% increase from 2020. With the COVID-19 pandemic now over, TB is once again the leading cause of death from a single infectious agent, with 1.4 million deaths among HIV-negative people and 187,000 deaths among HIV-positive people estimated in 2021...
Source: International Journal of Infectious Diseases - March 11, 2024 Category: Infectious Diseases Authors: Eskild Petersen, Seif Al-Abri, Amina Al Jardani, Ziad A Memish, Eleni Aklillu, Francine Ntoumi, Peter Mwaba, Christian Wejse, Alimuddin Zumla, Fatma Al-Yaquobi Tags: Review Source Type: research

A case of leprosy in a non endemic country
A dermatologist referred to our Infectious Diseases Centre a migrant who came to Italy from Nigeria for one-year-old diffuse, itchy, plane hypo-pigmented lesions with blurred edges and a tendency to conflate (Fig. 1A). Immunological, haematological and allergological investigations, a biopsy and empirical therapy with antifungals had yielded no diagnosis. This time the patient described an area of anaesthesia-dysesthesia on a leg, whose margin was biopsied again and used for microbiological investigation. (Source: International Journal of Infectious Diseases)
Source: International Journal of Infectious Diseases - March 11, 2024 Category: Infectious Diseases Authors: Erika Asperges, Jessica Bagnarino, Cinzia Ancarani, Ginevra Baggini, Matteo Filardo, Vincenzina Monzillo, Daniela Barbarini, Raffaele Bruno, Marco Paulli, Fausto Baldanti Tags: Medical Imagery Source Type: research

Spatial Heterogeneity of Nontuberculous Mycobacterial Pulmonary Disease in Shanghai: Insights from a Ten-Year Population-Based Study
Nontuberculous mycobacteria (NTM) are ubiquitous environmental organisms commonly found in water and soil [1, 2]. This diverse group encompasses approximately 200 identified species [3], some of which pose a risk to human health. NTM primarily infect the lungs and manifest clinical presentations that closely resemble pulmonary tuberculosis (TB) [1, 4]. The escalating prevalence of nontuberculous mycobacterial pulmonary disease (NTM-PD) is driven by a complex interplay of factors, including global population aging, underlying lung conditions such as chronic obstructive pulmonary disease (COPD), bronchiectasis, and cystic fi...
Source: International Journal of Infectious Diseases - March 8, 2024 Category: Infectious Diseases Authors: Yangyi Zhang, Ruoyao Sun, Chenlei Yu, Jing Li, Honghua Lin, Jinrong Huang, Ying Wang, Xin Shen, Yuan Jiang, Chongguang Yang, Biao Xu Source Type: research

Invasive Aspergillosis with Impaired Neutrophil Responses against Aspergillus fumigatus in Patients Treated with Acalabrutinib – findings from three cases
B-cell malignancies such as chronic lymphocytic leukemia (CLL) or Waldenstrom's macroglobulinemia are now commonly treated with inhibitors of Bruton's tyrosine kinase (BTK). Ibrutinib is a first-generation covalent BTK inhibitor (BTKi) and that was the first of its kind to be approved by the FDA. Ibrutinib was found to be a risk factor for the occurrence of invasive fungal complications, mainly invasive aspergillosis, of which up to 40% were complicated by cerebral involvement[1]. (Source: International Journal of Infectious Diseases)
Source: International Journal of Infectious Diseases - March 7, 2024 Category: Infectious Diseases Authors: Marion Blaize, Guillaume Thizy, Alexandre Boissonnas, Ana ïs Portalier, Fanny Lanternier, Clémentine de La Porte des Vaux, Felipe Suarez, Marie-Elisabeth Bougnoux, Juliette Guitard, Arnaud Jabet, Nicolas Stocker, Abdelmalek Aoudjhane, Damien Roos-Weil, Tags: Case Report Source Type: research

Corrigendum to “Extensive transmission of SARS-CoV-2 BQ.1* variant in a population with high levels of hybrid immunity: A prevalence survey” [International Journal of Infectious Diseases 139 (2024) 159-167]
The authors regret the funding information included in the final version of the article is incorrect. The correct funding information is: (Source: International Journal of Infectious Diseases)
Source: International Journal of Infectious Diseases - March 6, 2024 Category: Infectious Diseases Authors: Juan P. Aguilar Ticona, Meng Xiao, Dan Li, Jr. Nivison Nery, Matt Hitchings, Emilia M.M. Andrade Belitardo, Mariam O. Fofana, Renato Victoriano, Jaqueline S. Cruz, Laise de Moraes, Icaro Morais Strobel, Jessica Jesus Silva, Ananias Sena do Arag ão Filho, Tags: Corrigendum Source Type: research

World TB Day 2024 Theme “Yes! We Can End TB” can be made a reality through concerted global efforts that advance detection, diagnosis, and treatment of tuberculosis infection and disease
Every year, World TB Day is commemorated on March 24th, and is targeted at raising public and political awareness of tuberculosis (TB), a preventable and treatable disease. World TB Day commemorates the day in 1882 when Professor Robert Koch announced his discovery of the microbial cause of tuberculosis, the TB bacillus Mycobacterium tuberculosis. (Source: International Journal of Infectious Diseases)
Source: International Journal of Infectious Diseases - March 6, 2024 Category: Infectious Diseases Authors: Delia Goletti, Seif Al-Abri, Giovanni Battista Migliori, Cecilia Lindestam Arlehamn, Pranabashis Haldar, Christopher Sundling, Christopher da Costa, Kin Wang To, Adrian R. Martineau, Eskild Petersen, Alimuddin Zumla, Shui Shan Lee Tags: Editorial Source Type: research

Increased circulation of echovirus 11 in the general population and hospital patients as elicited by the non-polio enterovirus laboratory-based sentinel surveillance in northern Italy, 2023
Since the initial report of enterovirus (EV), echovirus 11 (E-11) infection in neonates in France in May 2023 [1], further cases have been reported in Italy and other European countries. The World Health Organization, having evaluated the limited data available, considers the public health risk to be low although countries are advised to investigate cases (https://www.who.int/emergencies/disease-outbreak-news/item/2023-DON474). Given that non-polio EV infections are not considered notifiable infectious diseases, this investigation aims to examine the circulation of E-11 in Lombardy (Northern Italy). (Source: International ...
Source: International Journal of Infectious Diseases - March 6, 2024 Category: Infectious Diseases Authors: Laura Pellegrinelli, Cristina Galli, Federica Giardina, Guglielmo Ferrari, Sara Colonia Uceda Renteria, Ferruccio Ceriotti, Arlinda Seiti, Sandro Binda, Antonino Maria Guglielmo Pitrolo, Roberta Schiavo, Sergio Maria Ivano Malandrin, Annalisa Cavallero, M Tags: Short Communication Source Type: research

Detection of Mycobacterium tuberculosis DNA in CD34+ peripheral blood mononuclear cells of adults with tuberculosis infection and disease
Tuberculosis (TB) is an infectious disease caused by Mycobacterium tuberculosis (Mtb) and represents a major public health threat worldwide, with 10.6 million cases and about 1.3 million deaths in 2022 [1]. For TB control and for reducing Mtb transmission it is crucial to diagnose TB infection (TBI) and identify the subset of infected people at highest risk of progression from infection to disease, who will benefit the most from preventive therapy [2]. Currently, there is no gold standard test for TBI diagnosis [3]. (Source: International Journal of Infectious Diseases)
Source: International Journal of Infectious Diseases - March 6, 2024 Category: Infectious Diseases Authors: Federica Repele, Tonino Alonzi, Assunta Navarra, Chiara Farroni, Andrea Salmi, Gilda Cuzzi, Giovanni Delogu, Gina Gualano, Vincenzo Puro, Gabriella De Carli, Enrico Girardi, Fabrizio Palmieri, Adrian R Martineau, Delia Goletti Source Type: research